To investigate the MDR-associated invasiveness of GBM using our drug-treated chemo-resistant cell model, we first measured relative expression of genes in the HIF1-α/VEGF/MMPs axis, which are linked to hypoxia and angiogenesis (Figure 7a(Fig. 7)). The gene discussed is VEGFA; the disease is glioblastoma.